Jin-shiung F. Cheng
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: February 21, 2025
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.
Journal: The Kaohsiung journal of medical sciences
Published: February 13, 2025
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Journal: Clinical and molecular hepatology
Published: January 16, 2024
Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study.
Journal: American journal of cancer research
Published: February 13, 2022
Randomized Controlled Study of Tenofovir versus Lamivudine Followed by Tenofovir in Severe Exacerbation of Hepatitis B.
Journal: Antimicrobial agents and chemotherapy
Published: November 22, 2021
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
Journal: Journal of hepatology
Published: August 31, 2021
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Journal: Hepatology international
Published: April 15, 2021
Hepatitis B Virus Screening Before Cancer Chemotherapy in Taiwan: A Nationwide Population-Based Study.
Journal: Frontiers in medicine
Published: January 22, 2021
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
Journal: Journal of gastroenterology and hepatology
Published: December 23, 2020
Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Patients with Liver Cirrhosis.
Journal: Pathogens (Basel, Switzerland)
Published: December 02, 2020
Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.
Journal: Journal of the Chinese Medical Association : JCMA
Published: November 24, 2020
Last Updated: 09/26/2026